Gyre Therapeutics, Inc. GYRE Gyre — Transaction Costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept gyre:TransactionCosts.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s gyre — transaction costs.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s gyre — transaction costs?
- Gyre Therapeutics, Inc. (GYRE) reported gyre — transaction costs of $2.55M in Q1 2026.
- What does gyre — transaction costs mean?
- These are the non-recurring expenses directly associated with executing specific business transactions, such as mergers, acquisitions, or divestitures. These costs are typically excluded from core operating performance to provide a clearer view of ongoing business health. Tracking these helps investors understand the impact of corporate development activities on the bottom line.